| Literature DB >> 31001018 |
Rizwana Shahid1, Azra Zafar1, Saima Nazish1, Abdulla Alsulaiman1, Majed Alabdali1, Danah Aljaafari1, Noman Ishaque1, Aishah Ibrahim Albakr1, Abdullah Alamri1, Fahd A Alkhamis1, Maher Saqqur2.
Abstract
OBJECTIVE: Our study aims to evaluate the etiologic and clinical features of cerebral venous sinus thrombosis (CVST) in Saudi Arabia, and secondarily whether gender plays a role in CVST.Entities:
Keywords: Cerebral venous thrombosis; etiology; gender; risk factors
Year: 2019 PMID: 31001018 PMCID: PMC6454937 DOI: 10.4103/jnrp.jnrp_305_18
Source DB: PubMed Journal: J Neurosci Rural Pract ISSN: 0976-3155
Clinical characteristics of the patients with cerebral venous sinus thrombosis (n=26)
| Demographics | Number of patients (%) |
|---|---|
| Age | 29.4 (15-49) |
| Gender | |
| Male | 11 (42.3) |
| Females | 15 (57.7) |
| Clinical presentation | |
| Headache | 17 (65.4) |
| Unilateral weakness | 14 (53.8) |
| Vomiting | 7 (26.9) |
| Seizures | 7 (26.9) |
| Visual symptoms | 2 (7.7) |
| Cranial nerve palsies | 10 (38.5) |
| Altered level of consciousness | 5 (19.2) |
| Neuro exam findings | |
| Nonfocal | 9 (34.6) |
| Abnormal | 15 (57.7) |
| Not known | 2 (7.7) |
| Risk factors | |
| OCP/postpartum | 6 (23) |
| Infections | 4 (15.3) |
| Trauma | 3 (11.5) |
| Hereditary thrombophilia | 3 (11.5) |
| Others | 2 (7.7) |
| Workup completed | 16 (61.5) |
| No risk factor identified | 3 (11.5) |
| More than one risk factor identified | 7 (26.9) |
| Acquired thrombophilia | 3 (11.5) |
| New cases of hereditary thrombophilia | 4 (15.3) |
| Treatment | |
| Warfarin | 10 (38.5) |
| Low-molecular-weight heparin | 6 (23.1) |
| New oral anticoagulants | 7 (26.9) |
| Other | 3 (11.5) |
OCP: Oral contraceptive pills
Radiological findings and details of thrombosed sinuses and veins
| Radiological findings | |
|---|---|
| CT/MRI findings | |
| Hemorrhagic venous infarction | 11 (40) |
| Nonhemorrhagic infarction | 6 (23.1) |
| Subarachnoid hemorrhage | 2 (7.6) |
| No parenchymal changes | 9 (34.6) |
| Dural venous sinuses involved | |
| Transverse | 19 (73) |
| SSS | 15 (57.7) |
| Sigmoid | 15 (57.7) |
| Others | 8 (30.7) |
| Single sinus involved | |
| SSS | 3 (11.5) |
| Two sites involvement | |
| Transverse + sigmoid | 9 (34.6) |
| Transverse + SSS | 8 (30.7) |
| SSS + sigmoid | 3 (11.5) |
| Sigmoid + ISS | 1 (3.8) |
| More than two sites involvement | 2 (7.7) |
| Follow-up imaging available | 15 (57.6) |
| Complete recanalization | 10 (38.5) |
| Partial recanalization | 3 (11.5) |
| No recanalization | 2 (7.7) |
CT: Computed tomography, MRI: Magnetic resonance imaging, SSS: Superior sagittal sinus, ISS: Inferior sagittal sinus
Demographic and clinical differences among males and females
| Gender | Females (15) | Males (11) | |
|---|---|---|---|
| Age | 32.33±9.93 | 25.45±5.55 | 0.02 |
| Clinical presentation | |||
| Headache | 12 | 3 | 0.067 |
| Vomiting | 2 | 5 | 0.069 |
| Unilateral weakness | 11 | 3 | 0.026 |
| Seizures | 4 | 3 | 0.65 |
| Dec level of consciousness | 1 | 4 | 0.08 |
| Visual symptoms | 2 | 0 | 0.32 |
| Cranial nerve palsies | 9 | 1 | 0.01 |
| Other | 4 | 2 | 0.49 |
| Intracranial hemorrhage | 8 | 3 | 0.17 |
| Infarction | 6 | 0 | 0.02 |
| Known premorbid etiology | |||
| Hereditary thrombophilia | 3 | 0 | 0.06 |
| Postpartum + OCP | 6 | N/A | |
| Trauma | 0 | 3 | |
| Complete etiological workup was done | |||
| Hereditary thrombophilia | 4 | 2 | 0.49 |
| Acquired prothrombotic condition | 3 | 3 | 0.50 |
| Infection | 1 | 4 | 0.06 |
| Posttrauma | 0 | 3 | 0.06 |
| Other | 5 | 2 | 0.34 |
| Dural venous sinuses involve | |||
| SSS | 9 | 6 | 0.54 |
| Sigmoid | 8 | 7 | 0.45 |
| Transverse | 10 | 9 | 0.34 |
| Other | 6 | 4 | 0.58 |
| Treatment | |||
| Warfarin | 6 | 4 | 0.58 |
| Low-molecular-weight heparin | 5 | 1 | 0.16 |
| New oral anticoagulants | 4 | 3 | 0.65 |
| Other | 0 | 3 | 0.06 |
SSS: Superior sagittal sinus, OCP: Oral contraceptive pills